Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2013 Jul 22;2013(7):ED000063.
doi: 10.1002/14651858.ED000063.

Folic acid supplementation for rheumatoid arthritis patients on methotrexate: the good gets better

Jasvinder A Singh  1
Affiliations
Editorial

Folic acid supplementation for rheumatoid arthritis patients on methotrexate: the good gets better

Jasvinder A Singh. Cochrane Database Syst Rev. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Shea B, Swinden MV, Tanjong Ghogomu E, Ortiz Z, Katchamart W, Rader T, et al. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. Cochrane Database of Systematic Reviews 2013;5:CD000951. doi.org/10.1002/14651858.CD000951.pub2 - PMC - PubMed
    1. Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN, et al. Efficacy of low‐dose methotrexate in rheumatoid arthritis. New England Journal of Medicine 1985;312(13):818–822. doi.org/10.1056/NEJM198503283121303 - PubMed
    1. Cronstein BN. Low‐dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacological Reviews 2005;57(2):163–172. doi.org/10.1124/pr.57.2.3 - PubMed
    1. Suarez‐Almazor ME, Belseck E, Shea B, Tugwell P, Wells GA. Methotrexate for treating rheumatoid arthritis. Cochrane Database of Systematic Reviews 2000(2):CD000957. doi.org/10.1002/14651858.CD000957 - PubMed
    1. Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care & Research 2012;64(5):625–639. doi.org/10.1002/acr.21641 - PMC - PubMed

MeSH terms

LinkOut - more resources